SCHEMBL4101091

SCHEMBL4101091

CCOC(=O)C1CCCCC1N(C)C(=N)N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 2/20 0.37
TAS1R1 Q7RTX1 2/20 0.37
MAPT P10636 1/20 0.36
ALDH1A1 P00352 1/20 0.35
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
F9 P00740 3/20 0.33
F10 P00742 2/20 0.33
PRSS1 P07477 1/20 0.33
PRSS2 P07478 1/20 0.33
PRSS3 P35030 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
GAA P10253 1/20 0.33
ALOX15 P16050 1/20 0.32
PPM1B O75688 1/20 0.32
PTPN1 P18031 1/20 0.32
PPP1CC P36873 1/20 0.32
EPHX1 P07099 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21522899 0.83 MAPT (0.39) TAS1R3TAS1R1MAPTALDH1A1TP53
SCHEMBL4093715 0.83 TAS1R3 (0.35) TAS1R3TAS1R1EPHX1
SCHEMBL21522857 0.80 MAPT (0.39) TAS1R3TAS1R1MAPTALDH1A1TP53
SCHEMBL4093494 0.78 ALDH1A1 (0.38) ALDH1A1EPHX1
SCHEMBL1481088 0.75 TP53 (0.41) TAS1R3TAS1R1MAPTALDH1A1TP53
SCHEMBL13011542 0.75 TP53 (0.53) TAS1R3TAS1R1MAPTALDH1A1TP53
SCHEMBL28405577 0.75 TP53 (0.53) TAS1R3TAS1R1MAPTALDH1A1TP53
SCHEMBL6900183 0.75 TP53 (0.53) TAS1R3TAS1R1MAPTALDH1A1TP53
SCHEMBL234644 0.75 TP53 (0.53) TAS1R3TAS1R1MAPTALDH1A1TP53
SCHEMBL7025154 0.74 NFKB1 (0.40) TAS1R3TAS1R1MAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090194124-A1 Hair Shaping Kit and Process Comprising at Least One Non-Hydroxide Imine MALLE GERARD 2009-08-06 US disclosed
US-20090139537-A1 HAIR RELAXING COMPOSITION COMPRISING AT LEAST ONE NON-HYDROXIDE IMINE L'OREAL S.A. 2009-06-04 US disclosed
US-20050136017-A1 Cosmetic containing an imine reactive with the cystines of keratin fibers via a beta-elimination reaction to produce dehydroalanine and lead to formation of lanthionine in a medium free of polyhydroxylated alkane; guanidine and/or amidine imines such as dimethylguanidine; noncaustic for use on hair, skin L'OREAL S.A. (FR) 2005-06-23 US disclosed
US-20050129645-A1 Hair shaping composition comprising at least one non-hydroxide imine L'OREAL 2005-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090139537-A1 HAIR RELAXING COMPOSITION COMPRISING AT LEAST ONE NON-HYDROXIDE IMINE KRT18, INMT, INHA TAS1R3 984/4885TAS1R1 972/4885MAPT 2845/4885
US-20090194124-A1 Hair Shaping Kit and Process Comprising at Least One Non-Hydroxide Imine KRT18, KIT, PRDM7 TAS1R3 1153/4885TAS1R1 1096/4885MAPT 2382/4885
US-20050129645-A1 Hair shaping composition comprising at least one non-hydroxide imine KRT18, INHA, H1-5 TAS1R3 805/4885TAS1R1 755/4885MAPT 2407/4885
US-20050136017-A1 Cosmetic containing an imine reactive with the cystines of keratin fibers via a beta-elimination reaction to produce dehydroalanine and lead to formation of lanthionine in a medium free of polyhydroxylated alkane; guanidine and/or amidine imines such as dimethylguanidine; noncaustic for use on hair, skin BHMT, KRT18, INMT TAS1R3 1233/4885TAS1R1 929/4885MAPT 3332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.